Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trial
Tarih
2006Yazar
Sut, Necdet
Mert, A
Ozbay, Gülşen
Tabak, F
Midilli, Kenan
Ozaras, Reşat
Canbakan, B
Senturk, H
Akdogan, M
Tahan, V
Üst veri
Tüm öğe kaydını gösterÖzet
Background and Aim: Delta hepatitis is characterized by rapidly progressive liver disease with adverse prognosis in most patients. Patients benefit from high doses and prolonged courses of interferon (IFN) therapy; however, lamivudine as a single agent has been disappointing. Data relating to the efficacy of IFN and lamivudine in combination is limited. The aim of this study was to test the efficacy of IFN-alpha 2b and lamivudine combination treatment in comparison to IFN-alpha 2b alone in patients with chronic delta hepatitis.
Koleksiyonlar
- Makale [92796]